A multicenter study of antimicrobial resistance of clinical strains of pneumococci in Kyrgyzstan

Berik Emilov (Bishkek, Kyrgyzstan), Berik Emilov, Mairam Alybaeva, Ainura Ergeshova, Bermet Estebesova, Barton Smith, Talant Sooronbaev

Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Session: Microbiological issues and translational research in respiratory infections
Session type: Thematic Poster
Number: 2616
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Berik Emilov (Bishkek, Kyrgyzstan), Berik Emilov, Mairam Alybaeva, Ainura Ergeshova, Bermet Estebesova, Barton Smith, Talant Sooronbaev. A multicenter study of antimicrobial resistance of clinical strains of pneumococci in Kyrgyzstan. Eur Respir J 2016; 48: Suppl. 60, 2616

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Dynamic of resistance of streptococcus pneumoniae strains from patients with CAP in theritary tertyary hospital: 10 years prospective study
Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Year: 2016


Feasibility study for a randomized controlled trial of pseudomonas aeruginosa eradication treatment in patients with bronchiectasis
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook
Year: 2015


Antibiotic resistance genotype trend and association with host clinical characteristics in respiratory isolates of streptococcus pneumoniae
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014


Low frequency of resistant pathogens in nursing home acquired pneumonia: A prospective study and systematic review
Source: Annual Congress 2013 –Recent developments in pneumonia
Year: 2013


Concurrent use of bedaquiline and delamanid for the treatment of fluoroquinolone-resistant multidrug-resistant tuberculosis: a nationwide cohort study in South Korea
Source: Eur Respir J, 57 (3) 2003026; 10.1183/13993003.03026-2020
Year: 2021



Risk factors for multidrug resistant bacteria in Hospital-Acquired Pneumonia: A three-year cohort study
Source: Annual Congress 2010 - Unusual pathogens in respiratory infections
Year: 2010


Clofazimine for the treatment of multidrug-resistant tuberculosis: Prospective, multicenter, randomized controlled study in China
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015

Multidrug resistant acinetobacter baumanii pneumonia: Mortality analysis and comparison of intravenous versus aerosolized therapy
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014


Prevention of MRSA pneumonia by oral vancomycin decontamination: a randomised trial
Source: Eur Respir J 2004; 23: 921-926
Year: 2004



Clinical outcomes of the patients with multidrug-resistant Acinetobacter baumannii pneumonia in critical care setting: A retrospective cohort study in Taiwan
Source: International Congress 2018 – Preclinical and clinical studies of critical illness
Year: 2018


A randomized, open-label, multicenter study of liposomal amikacin for inhalation in adult patients with nontuberculous mycobacteria (NTM) lung infections caused by mycobacterium avium complex (MAC)
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015

Evaluation of optimal regimens for treatment of rifampicin resistant-tuberculosis: Multicenter, randomized controlled study in China
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015

Antimicrobial susceptibility of stenotrophomonas maltophilia isolated from respiratory specimens from a tertiary care center in Pakistan
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013


Monitoring of antimicrobial resistance respiratory strains of streptococcus pneumoniae
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014


Antibiotic resistance and clinical outcomes: the CAPNETZ experience
Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections
Year: 2006



Prospective study of nosocomial spread of tuberculosis
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I
Year: 2012


Empiric penicillin monotherapy of CAP is not associated with increased mortality; experiences from the retrospective CAP-North cohort
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016


Risk factors and outcomes of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa: a clinical case-control study
Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes
Year: 2017

GRACE-01 Genomics to combat resistance against antibiotics in community-acquired LRTI in Europe – a multicentre, observational cohort study of cough/LRTI in primary care
Source: Annual Congress 2007 - Clinical trial: antibiotic use in the community
Year: 2007


Increasing global resistance to penicillin, macrolides and other antimicrobials among isolates of Streptococcus pneumoniae: susceptibility data from three years of the PROTEKT surveillance study
Source: Eur Respir J 2003; 22: Suppl. 45, 486s
Year: 2003